More recently, Honda et al. developed the ELISA for measurement of APOAII-2 and performed multi-institutional validation of the usefulness of APOAII-2 as a pancreatic cancer biomarker [18]. The gene discussed is APOA2; the disease is pancreatic neoplasm.